CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Open-market buy Director bought 2,000 shares at $5.75 ($11,500)
- 4 Open-market buy Director bought 1,500 shares at $5.63 ($8,445)
- 4 Open-market buy Director bought 5,548 shares at $5.71 ($31,679)
- 4 Open-market buy Director bought 7,000 shares at an average $5.47 ($38,300)
- 4 Open-market buy President and CEO bought 5,000 shares at $5.77 ($28,850)
- 4 Open-market buy Director bought 5,000 shares at $5.69 ($28,450)
- 4 Open-market buy Director bought 1,500 shares at $5.99 ($8,985)
- 4 Open-market buy Director bought 2,000 shares at an average $5.41 ($10,820)
- 4 Open-market buy Director bought 4,400 shares at an average $5.46 ($24,034)
- 4 Open-market buy Director bought 9,400 shares at an average $5.46 ($51,320)
- 4 Open-market buy President and CEO bought 200 shares at $4.00 ($800)
- 4 Open-market buy Director bought 6,500 shares at $3.62 ($23,530)
- 4 Open-market buy President and CEO bought 200 shares at $3.80 ($760)
- 4 Open-market buy Director bought 3,500 shares at $3.94 ($13,790)
- 4 Open-market buy Director bought 1,700 shares at $3.98 ($6,766)
- 4 Open-market buy President and CEO bought 1,100 shares at an average $3.84 ($4,225)
- 4 Open-market buy President and CEO bought 1,712 shares at an average $4.24 ($7,258)
- 4 Open-market buy Director bought 2,000 shares at $3.95 ($7,900)
- 4 Open-market buy Director bought 6,000 shares at $3.95 ($23,700)
- 4 Open-market buy Director bought 100 shares at $8.95 ($895)
Page 14 of 24 · 471 filings